Get started
Author

Lourdes Gombau

Observed names: Gombau, Lourdes, L Gombau, L. Gombau
Observed institutions: Scripps Research Institute, Hospital Universitari i Politècnic La Fe, Institut d'Investigació Biomédica de Bellvitge, Leitat Technological Center, Parc Científic de Barcelona, NILU
ORCID: 0000-0002-2456-157X
Observed ORCID: 0000-0002-2456-157X
OpenAlex ID: A5058411556
Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: A quantitative method for oxidative stress assessment of nanoparticle-treated cells
2013 · A. Aranda, L. Sequedo, et al. · Toxicology in Vitro · 507
Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices
2014 · David E. Lefebvre, Koen Venema, et al. · Nanotoxicology · 146
Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food‐relevant nanomaterials
2015 · Susann Bellmann, David Carlander, et al. · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 137
PDF
In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs
2010 · M.J. Gomez-Lechon, A. Lahoz, et al. · Current Pharmaceutical Design · 123
Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST
2015 · M. Dusinska, S. Boland, et al. · Nanotoxicology · 101
PDF
Plasma sample based analysis of gastric cancer progression using targeted metabolomics
2017 · Sergio Lario, Maria José Ramírez-Lázaro, et al. · Scientific Reports · 97
PDF
Polypodium leucotomos extract: Antioxidant activity and disposition
2005 · L. Gombau, F. García, et al. · Toxicology in Vitro · 83
Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles
2015 · Hilary Cowie, Zuzana Magdolenova, et al. · Nanotoxicology · 66
Testing Strategies for The Safety of Nanoparticles Used in Medical Applications
2009 · Maria Dusinska, M Dusinska, et al. · Nanomedicine · 65
Metabolomic Analysis of Gastric Cancer Progression within the Correa’s Cascade Using Ultraperformance Liquid Chromatography–Mass Spectrometry
2016 · Julia Kuligowski, Daniel Sanjuan-Herráez, et al. · Journal of Proteome Research · 53
The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: Results from the European Project ACuteTox
2012 · P. Prieto, A. Kinsner-Ovaskainen, et al. · Toxicology in Vitro · 47
Report from the EPAA workshop: In vitro ADME in safety testing used by EPAA industry sectors
2010 · K. Schroeder, K.D. Bremm, et al. · Toxicology in Vitro · 42
PDF
Plasmin-mediated Release of the Guidance Molecule F-spondin from the Extracellular Matrix
2001 · Vered Tzarfaty-Majar, Roser López-Alemany, et al. · Journal of Biological Chemistry · 39
Marine-Derived Surface Active Agents: Health-Promoting Properties and Blue Biotechnology-Based Applications
2020 · Ioannis Anestopoulos, Despina-Evgenia Kiousi, et al. · Biomolecules · 33
PDF
In Vitro ADME Medium/High-Throughput Screening in Drug Preclinical Development
2006 · A. Lahoz, L. Gombau, et al. · Mini-Reviews in Medicinal Chemistry · 32
Detection of batch effects in liquid chromatography-mass spectrometry metabolomic data using guided principal component analysis
2014 · J. Kuligowski, D. Pérez-Guaita, et al. · Talanta · 31
Regulated Secretion Is Impaired in AtT-20 Endocrine Cells Stably Transfected with Botulinum Neurotoxin Type A Light Chain
1997 · Fernando Aguado, Lourdes Gombau, et al. · Journal of Biological Chemistry · 19
PDF
Processing of type 1 plasminogen activator inhibitor (PAI-1) into the regulated secretory pathway.
1994 · L. Gombau, R.R. Schleef · Journal of Biological Chemistry · 18
In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs
2010 · M. J. Gomez-Lechon, A. Lahoz, et al. · Current Pharmaceutical Design · 14
Methylazoximethanol acetate-induced cell death in the granule cell layer of the developing mouse cerebellum is associated with caspase-3 activation, but does not depend on the tissue-type plasminogen activator
2001 · Isidro Ferrer, Berta Puig, et al. · Neuroscience Letters · 12
Human glioma U‐251 cells contain type 1 plasminogen activator inhibitor in a rapidly releasable form
1996 · Eeva-Marjatta Salonen, Lourdes Gombau, et al. · FEBS Letters · 5
PDF
Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics. NanoTEST – EC FP7 project
2009 · Maria Dusinska, Lise Maria Fjellsbo, et al. · Journal of Physics Conference Series · 4
PDF
Vertical Membrane‐Free Organ‐on‐a‐Chip for High‐Throughput In Vitro Studies and Drug Screening
2025 · Xavier Barceló, Pooya Azizian, et al. · Advanced Materials Technologies · 2
Silicon-based nanopillars: a novel platform for tissue applications
2025 · Cristiano Piergallini, Natalia Díaz-Valdivia, et al. · Biomaterials Science · 2
PDF
Author response for "Silicon-based nanopillars: a novel platform for tissue applications"
2025 · Cristiano Piergallini, Natalia Díaz-Valdivia, et al. · Publons reviews and discussion
Works count: 31
Citation count: 1,678
H-index: 18
I10-index: 20
Year
Topic
Type